A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2

The development of safe and effective vaccines to prevent SARS-CoV-2 infections remains an urgent priority worldwide. We have used a recombinant vesicular stomatitis virus (rVSV)-based prime-boost immunization strategy to develop an effective COVID-19 vaccine candidate. We have constructed VSV genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gyoung Nyoun, Choi, Jung-ah, Wu, Kunyu, Saeedian, Nasrin, Yang, Eunji, Park, Hayan, Woo, Sun-Je, Lim, Gippeum, Kim, Seong-Gyu, Eo, Su-Kyeong, Jeong, Hoe Won, Kim, Taewoo, Chang, Jae-Hyung, Seo, Sang Hwan, Kim, Na Hyung, Choi, Eunsil, Choo, Seungho, Lee, Sangkyun, Winterborn, Andrew, Li, Yue, Parham, Kate, Donovan, Justin M., Fenton, Brock, Dikeakos, Jimmy D., Dekaban, Gregory A., Haeryfar, S. M. Mansour, Troyer, Ryan M., Arts, Eric J., Barr, Stephen D., Song, Manki, Kang, C. Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675757/
https://www.ncbi.nlm.nih.gov/pubmed/34914812
http://dx.doi.org/10.1371/journal.ppat.1010092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8675757/
https://www.ncbi.nlm.nih.gov/pubmed/34914812
http://dx.doi.org/10.1371/journal.ppat.1010092

Ejemplares similares